Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


SVLSF IV, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2021 SC 13D/A SVLSF IV, LLC reports a 0% stake in KALVISTA PHARMACEUTICALS, INC.
11/14/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/14/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/15/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
04/10/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 22,171 shares @ $29.4919, valued at $653.9k
Sold 629 shares @ $29.4919, valued at $18.6k
Sold 13,292 shares @ $28.5305, valued at $379.2k
Sold 377 shares @ $28.5305, valued at $10.8k
Sold 13,157 shares @ $29.3952, valued at $386.8k
Sold 374 shares @ $29.3952, valued at $11k
04/03/2019 SC 13D/A SVLSF IV, LLC reports a 10.3% stake in KALVISTA PHARMACEUTICALS, INC.
04/02/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 34,133 shares @ $28.396, valued at $969.2k
Sold 969 shares @ $28.396, valued at $27.5k
Sold 51,373 shares @ $27.6582, valued at $1.4M
Sold 1,458 shares @ $27.6582, valued at $40.3k
Sold 8,888 shares @ $28.7638, valued at $255.7k
Sold 253 shares @ $28.7638, valued at $7.3k
03/28/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 29,262 shares @ $29.6975, valued at $869k
Sold 831 shares @ $29.6975, valued at $24.7k
Sold 56,318 shares @ $29.0592, valued at $1.6M
Sold 1,599 shares @ $29.0592, valued at $46.5k
Sold 35,653 shares @ $27.801, valued at $991.2k
Sold 1,012 shares @ $27.801, valued at $28.1k
03/20/2019 SC 13D/A SVLSF IV, LLC reports a 11.5% stake in KALVISTA PHARMACEUTICALS, INC.
03/20/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 255,224 shares @ $26.7, valued at $6.8M
Sold 7,246 shares @ $26.7, valued at $193.5k
03/06/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 42,181 shares @ $22.907, valued at $966.2k
Sold 1,197 shares @ $22.907, valued at $27.4k
Sold 31,439 shares @ $23.0365, valued at $724.2k
Sold 893 shares @ $23.0365, valued at $20.6k
02/26/2019 SC 13D/A SVLSF IV, LLC reports a 13.5% stake in KALVISTA PHARMACEUTICALS, INC.
02/21/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 17,912 shares @ $20.7328, valued at $371.4k
Sold 508 shares @ $20.7328, valued at $10.5k
Sold 22,594 shares @ $20.0159, valued at $452.2k
Sold 641 shares @ $20.0159, valued at $12.8k
Sold 167,779 shares @ $20.6, valued at $3.5M
Sold 4,764 shares @ $20.6, valued at $98.1k
02/14/2019 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/07/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 1,653 shares @ $20.013, valued at $33.1k
Sold 47 shares @ $20.013, valued at $940.6
Sold 2,527 shares @ $20.412, valued at $51.6k
Sold 72 shares @ $20.412, valued at $1.5k
01/02/2019 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 3,631 shares @ $20.027, valued at $72.7k
Sold 103 shares @ $20.027, valued at $2.1k
Sold 24,716 shares @ $20.004, valued at $494.4k
Sold 702 shares @ $20.004, valued at $14k
Sold 194 shares @ $20, valued at $3.9k
Sold 6 shares @ $20, valued at $120
12/21/2018 4 SVLSF IV, LLC (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 2,077 shares @ $20.018, valued at $41.6k
Sold 59 shares @ $20.018, valued at $1.2k
11/14/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/06/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/15/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
03/02/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2018 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
12/29/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/11/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/14/2017 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/10/2017 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/01/2017 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice
03/02/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/07/2017 SC 13G/A SVLSF IV, LLC reports a 6.6% stake in TransEnterix, Inc.
02/07/2017 SC 13G/A Lombard Medical, Inc. reports a 4.6% stake in LOMBARD MEDICAL, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy